MoneyWorks4Me

Windlas Biotech - Quaterly Results

08 Aug 2023 Evaluate
The revenue zoomed 20.72% to Rs. 1447.86 millions for the quarter ended June 2023 as compared to Rs. 1199.36 millions during the corresponding quarter last year.A humble growth in net profit of 23.12% reported in the quarter ended June 2023 to Rs. 120.66  millions from Rs. 98.00 millions.OP of the company witnessed a marginal growth to 197.67 millions from 166.50 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1447.86 1199.36 20.72 1447.86 1199.36 20.72 5130.83 4659.30 10.12
Other Income 26.24 28.58 -8.19 26.24 28.58 -8.19 99.65 67.06 48.60
PBIDT 197.67 166.50 18.72 197.67 166.50 18.72 702.07 596.01 17.80
Interest 2.37 3.50 -32.29 2.37 3.50 -32.29 7.86 14.17 -44.53
PBDT 195.30 163.00 19.82 195.30 163.00 19.82 694.21 581.84 19.31
Depreciation 31.89 27.56 15.71 31.89 27.56 15.71 123.64 121.47 1.79
PBT 163.41 135.44 20.65 163.41 135.44 20.65 570.57 460.37 23.94
TAX 42.75 37.44 14.18 42.75 37.44 14.18 144.13 74.76 92.79
Deferred Tax 2.94 0.96 206.25 2.94 0.96 206.25 0.63 -26.57 -102.37
PAT 120.66 98.00 23.12 120.66 98.00 23.12 426.44 385.61 10.59
Equity 103.99 108.97 -4.57 103.99 108.97 -4.57 104.63 108.97 -3.98
PBIDTM(%) 13.65 13.88 -1.66 13.65 13.88 -1.66 13.68 12.79 6.97
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..